Not applicableStudy completedNCT00769184What this trial is testingCombining Topical Corticosteroid and LCD Treatment for Localized Plaque PsoriasisWho this might be right forPsoriasis NeoStrata Company, Inc. 15
Large-scale testing (Phase 3)UnknownNCT06477237What this trial is testingStudy of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Huabo Biopharm Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT04123795What this trial is testingEvaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forModerate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis UCB Biopharma SRL 49
Large-scale testing (Phase 3)Study completedNCT02698475What this trial is testingAn Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of AgeWho this might be right forPsoriasis Janssen Research & Development, LLC 44
Large-scale testing (Phase 3)Study completedNCT04453137What this trial is testingPharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Alvotech Swiss AG 567
Testing effectiveness (Phase 2)Study completedNCT01132612What this trial is testingAIN457 Regimen Finding Extension Study in Participants With Moderate to Severe PsoriasisWho this might be right forPlaque-type Psoriasis Novartis Pharmaceuticals 275
Large-scale testing (Phase 3)Study completedNCT02714322What this trial is testingMYL-1401A Efficacy and Safety Comparability Study to Humira®Who this might be right forPsoriasisArthritis, Psoriatic Mylan Inc. 294
Not applicableStudy completedNCT00799877What this trial is testingChronic Plaque Psoriasis (Ps) RegistryWho this might be right forChronic Plaque Psoriasis AbbVie 6,065
Post-approval studies (Phase 4)Study completedNCT03718299What this trial is testingA Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With PsoriasisWho this might be right forPsoriasis Sun Pharmaceutical Industries Limited 55
Testing effectiveness (Phase 2)Study completedNCT04080206What this trial is testingA Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque PsoriasisWho this might be right forPlaque Psoriasis Therapeutics, Inc. 55
Not applicableStudy completedNCT01401452What this trial is testingEffectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbiditiesWho this might be right forModerate to Severe Plaque Psoriasis AbbVie (prior sponsor, Abbott) 246
Not applicableStudy completedNCT05787236What this trial is testingModerate-to-severe Plaque Psoriasis Patients Response to Secukinumab Treatment in Real-world SettingWho this might be right forModerate-to-severe Plaque Psoriasis Novartis Pharmaceuticals 79
Large-scale testing (Phase 3)Ended earlyNCT02527421What this trial is testingDFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Primus Pharmaceuticals 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090330What this trial is testingORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Oruka Therapeutics, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT03384745What this trial is testingA Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe PsoriasisWho this might be right forPsoriasis Bond Avillion 2 Development LP 313
Testing effectiveness (Phase 2)Study completedNCT01988103What this trial is testingEfficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisWho this might be right forPsoriasisPsoriatic ArthritisPsoriasis Arthropatica Amgen 254
Post-approval studies (Phase 4)Study completedNCT03988439What this trial is testingA Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 16
Large-scale testing (Phase 3)Study completedNCT01276639What this trial is testingA One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 901
Testing effectiveness (Phase 2)Study completedNCT02413229What this trial is testingDouble Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical StudyWho this might be right forPlaque Psoriasis Sun Pharmaceutical Industries, Inc. 151
Large-scale testing (Phase 3)Study completedNCT03210259What this trial is testingThe VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque PsoriasisWho this might be right forPsoriasis Boehringer Ingelheim 259